AMGN
AMGN
NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$415.21
-2.63 (-0.63%)
As of Aug 15, 1:00 AM ET ·
Analyst Consensus
Hold
43
Analysts
Very High
Coverage
Buy 21 49%
Hold 19 44%
Sell 3 7%
Price Target
Analyst Price Target -54.0% upside
Low Target $141.50
Average Target $190.87
High Target $279.75
Current Price $415.21
Current
$415.21
Target
$190.87
$141.50 $190.87 avg $279.75
Scenario Analysis
Bear Case
$141.50
-65.9%
Low target
Base Case
$190.87
-54.0%
Avg target
Bull Case
$279.75
+-32.6%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$421.79
-1.6% from high
52-Week Low
$269.77
+53.9% from low
50-Day SMA
$340.27
+22.0% vs SMA
200-Day SMA
$306.48
+35.5% vs SMA
RSI (14)
67.1
Neutral
Target vs 52W High
$190.87
-54.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%